DOUBLE DOSE - Teva Pharmaceutical Industries was hit with an antitrust class action Friday in New Jersey District Court in relation to its multiple sclerosis drug, Copaxone. The suit contends that Teva used coercive tactics to switch the market from 20mg to 40mg to suppress generic competition. The complaint was filed by Seeger Weiss; Wexler Boley & Elgersma; and Rupp Baase Pfalzgraf Cunningham. Counsel have not yet appeared for the defendants. The case is 2:22-cv-01345, Labor-Management Healthcare Fund v. Teva Pharmaceuticals Industries Ltd. et al. Stay up on the latest deals and litigation with the new Law.com Radar.
EDITOR’S PICKS
You Might Like
Law Firms Mentioned
Trending Stories
-
Featured Firms
Law Offices of Gary Martin Hays & Associates P.C.75 Ponce De Leon Ave NE Ste 101Atlanta, GA 30308(470) 294-1674www.garymartinhays.comLaw Offices of Mark E. Salomone2 Oliver St #608Boston, MA 02109(857) 444-6468www.marksalomone.comSmith & Hassler1225 N Loop W #525Houston, TX 77008(713) 739-1250www.smithandhassler.comPresented by BigVoodoo
More From ALM
View Now
View Now
View Now
Aurora, CO
The premier educational and networking event for employee benefits brokers and agents.
Learn More
Philadelphia, PA
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Learn More
Dallas, TX
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Learn More
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Apply Now ›
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Apply Now ›
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
Apply Now ›
Connecticut Law Tribune
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
View Announcement ›